<!DOCTYPE html>
<html>
<head>
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>      
	<style>
	.show {display: block;}
  .tablist-left {
    width: 25%;
    display: inline-block;
  }
  .tablist-content {
    width: 60%;
    display: inline-block;
    vertical-align: top;
    margin-left: 5%;
    }
    body {
  font-family: Arial, Helvetica, sans-serif;
  font-size: 20px;
}
.footer-button-left,
.footer-button-right {
    position: absolute;
    margin: 0;
    top: auto;
    bottom: 0.24em;
}
.footer-button-left {
    left: 0.4em;
}
.footer-button-right {
    right: 0.4em;
}
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Lucida Grande";}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:18.0pt;
	margin-left:0cm;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:9.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-weight:normal;
	font-style:italic;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:9.0pt;
	font-family:"Lucida Grande","sans-serif";}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Lucida Grande","sans-serif";}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Arial","sans-serif";}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-style:italic;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	color:#605E5C;
	background:#E1DFDD;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	font-family:"Arial","sans-serif";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Tahoma","sans-serif";}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
   .tableCont {
    overflow: auto;
    -webkit-overflow-scrolling: touch;
}
  </style>
  	  	<script>
		$(function(){
			$( "[data-role='header'], [data-role='footer']" ).toolbar();
			$('input[data-type="search"]').val("");			
		});
		// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}
	</script>

</head>
<body lang=EN-GB link=blue vlink=purple>
	<div data-role="header" data-tap-toggle="false" data-id="persistent-header" data-position="fixed" data-theme="a">
		<h2 style="font-size:0.75em;"><br><br><br>MRCG<br>Clinical Guidelines</h2>
		<a data-rel="back" class="ui-btn ui-corner-all ui-btn-inline ui-mini header-button-left ui-btn-icon-left ui-icon-carat-l">Back</a>
		<a href="#leftpanel1" class="ui-btn ui-shadow ui-corner-all ui-btn-inline ui-mini header-button-left ui-icon-info ui-btn-icon-notext">About this app</a>
		<a href="#popupNested"  data-rel="popup" class="ui-btn ui-corner-all ui-shadow ui-btn-inline ui-icon-bars ui-btn-icon-right ui-btn-b header-button-right" data-transition="pop">Choose a guideline...</a>
		<div data-role="popup" id="popupNested" data-theme="a"><ul data-role="listview" data-filter="true"data-filter-placeholder="Type to search names..." data-inset="true">
			<li><a href="Acute_kidney_injury_MeG-CLS-071.html">Acute kidney injury</a></li>
			<li><a href="Acute_rheumatic_fever__MeG-CLS-048.html">Acute rheumatic fever </a></li>
			<li><a href="Animal_bites_MeG-CLS-049.html">Animal bites</a></li>
			<li><a href="Asthma_MeG-CLS-001.html">Asthma</a></li>
			<li><a href="Bone_and_joint_infections_guidelines_MeG-CLS-050.html">Bone and joint infections guidelines</a></li>
			<li><a href="Cellulitis_MeG-CLS-051.html">Cellulitis</a></li>
			<li><a href="Chest_pain_and_Acute_Coronary_Syndrome_MeG-CLS-052.html">Chest pain and Acute Coronary Syndrome</a></li>
			<li><a href="Chronic_kidney_disease_MeG-CLS-053.html">Chronic kidney disease</a></li>
			<li><a href="Congenital_heart_disease_MeG-CLS-039.html">Congenital heart disease</a></li>
			<li><a href="Constipation_MeG-CLS-003.html">Constipation</a></li>
			<li><a href="COPD_MeG-CLS-032.html">Chronic Obstructive Pulmonary Disease</a></li>
			<li><a href="Croup_MeG-CLS-059.html">Croup</a></li>
			<li><a href="Deep_venous_thombosis_and_pulmonary_embolism_MeG-CLS-055.html">Deep venous thombosis and pulmonary embolism</a></li>
			<li><a href="Depression_MeG-CLS-075.html">Depression</a></li>
			<li><a href="Developmental_delay_MeG-CLS-054.html">Developmental delay</a></li>
			<li><a href="Diabetes_Mellitus_MeG-CLS-004.html">Diabetes Mellitus</a></li>
			<li><a href="DKA_MeG-CLS-021.html">Diabetic ketoacidosis</a></li>
			<li><a href="Dyspepsia_MeG-CLS-034.html">Dyspepsia</a></li>
			<li><a href="Ear_pain_MeG-CLS-070.html">Ear pain</a></li>
			<li><a href="Epiglottitis_MeG-CLS-063.html">Epiglottitis</a></li>
			<li><a href="Epilepsy_MeG-CLS-056.html">Epilepsy</a></li>
			<li><a href="Fungal_Skin_Infections_MeG-CLS-057.html">Fungal Skin Infections</a></li>
			<li><a href="Gastroenteritis_MeG-CLS-033.html">Gastroenteritis</a></li>
			<li><a href="General_Body_Pain_MeG-CLS-007.html">General Body Pain</a></li>
			<li><a href="Headache_MeG-CLS-045.html">Headache</a></li>
			<li><a href="Heart_failure_adults_MeG-CLS-040.html">Heart failure adults</a></li>
			<li><a href="HHS_MeG-CLS-046.html">Hyperosmolar Hyperglycaemic State</a></li>
			<li><a href="HIV_MeG-CLS-035.html">HIV</a></li>
			<li><a href="Hypertension_MeG-CLS-010.html">Hypertension</a></li>
			<li><a href="Hyperthyroidism_and_goitre_MeG-CLS-027.html">Hyperthyroidism and goitre</a></li>
			<li><a href="Hypocalcaemia_and_hypercalcaemia_MeG-CLS-074.html">Hypocalcaemia and hypercalcaemia</a></li>
			<li><a href="Hypokalaemia_hyperkalaemia_hypermagnesaemia_MeG-CLS-073.html">Hypokalaemia, hyperkalaemia, hypermagnesaemia</a></li>
			<li><a href="Hyponatraemia_and_hypernatraemia_MeG-CLS-072.html">Hyponatraemia and hypernatraemia</a></li>
			<li><a href="Hypothyroidism_MeG-CLS-036.html">Hypothyroidism</a></li>
			<li><a href="Infective_Endocarditis_MeG-CLS-058.html">Infective Endocarditis</a></li>
			<li><a href="Inflammatory_arthritis_and_connective_tissue_disease_MeG-CLS-041.html">Inflammatory arthritis and connective tissue disease</a></li>
			<li><a href="Intestinal_helminths_MeG-CLS-009.html">Intestinal helminths</a></li>
			<li><a href="Liver_disease_MeG-CLS-031.html">Liver disease</a></li>
			<li><a href="Lower_back_pain_MeG-CLS-022.html">Lower back pain</a></li>
			<li><a href="LRI_MeG-CLS-011.html">Lower Respiratory Infections</a></li>
			<li><a href="Malaria_MeG-CLS-012.html">Malaria</a></li>
			<li><a href="Malnutrition_MeG-CLS-037.html">Malnutrition</a></li>
			<li><a href="Meningitis_MeG-CLS-028.html">Meningitis</a></li>
			<li><a href="Neonatal_jaundice_MeG-CLS-060.html">Neonatal jaundice</a></li>
			<li><a href="Nephrotic_Syndrome_MeG-CLS-061.html">Nephrotic Syndrome</a></li>
			<li><a href="Osteoarthritis_MeG-CLS-042.html">Osteoarthritis</a></li>
			<li><a href="Otitis_media_MeG-CLS-023.html">Otitis media</a></li>
			<li><a href="Palliative_Care_MeG-CLS-064.html">Palliative Care</a></li>
			<li><a href="Rectal_prolapse_MeG-CLS-015.html">Rectal prolapse</a></li>
			<li><a href="Rheumatic_heart_disease_MeG-CLS-065.html">Rheumatic heart disease</a></li>
			<li><a href="Scabies_MeG-CLS-066.html">Scabies</a></li>
			<li><a href="Sepsis_in_adults_MeG-CLS-043.html">Sepsis in adults</a></li>
			<li><a href="Sinusitis_MeG-CLS-062.html">Sinusitis</a></li>
			<li><a href="Stevens-Johnsons_syndrome_MeG-CLS-067.html">Stevens-Johnsons syndrome</a></li>
			<li><a href="STI_MeG-CLS-038.html">Sexually Transmitted Infections</a></li>
			<li><a href="Stroke_MeG-CLS-020.html">Stroke</a></li>
			<li><a href="TB_MeG-CLS-044.html">TB</a></li>
			<li><a href="Tonsillitis_and_pharyngitis_MeG-CLS-024.html">Tonsillitis and pharyngitis</a></li>
			<li><a href="Trauma_MeG-CLS-068.html">Trauma</a></li>
			<li><a href="Upper_respiratory_tract_infections_MeG-CLS-018.html">Upper respiratory tract infections</a></li>
			<li><a href="UTI_MeG-CLS-019.html">Urinary tract infections</a></li>
</ul>
	  </div>
	  </div>
	 
    </div><!-- /header -->
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Stroke</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>A stroke is the sudden loss of neurological
function resulting from death of brain tissue from vascular occlusion or
rupture. </span></p>
<p class=MsoNormal><span lang=EN-US>Stroke is the second leading cause of death
globally and the number one cause of functional disability. It is a feared
complication of hypertension, diabetes mellitus and heart disease. </span></p>
<p class=MsoNormal><span lang=EN-US>The gold standard for stroke treatment
includes an early CT scan to rule out bleeding followed by thrombolysis. These
are not readily available in The Gambia but should not prevent our patients
from receiving the best possible care that is available. </span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target users</span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target area
of use </span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Gate clinic</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Key areas of
focus / New additions / Changes </span></h3>
<p class=MsoNormal><span lang=EN-US>This guideline covers the diagnoses and
management of stroke. It updates the previous guideline on acute stroke care.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients suspected to have suffered a
stroke should be sent from the Gate Clinic to the ward for urgent review by a
doctor.</span></p>
<p class=MsoNormal><span lang=EN-US>The ROSIER score can assist the doctor in
diagnosis if the presentation is unclear.</span></p>
<p class=MsoNormal><span lang=EN-US>For patients presenting in Keneba, refer
after emergency care.</span></p>
<p class=MsoNormal><span lang=EN-US>Ideally, patients should have a
non-contrast cranial CT scan to rule out haemorrhage. Treatment on the ward
involves maintenance of hydration, management of intracranial pressure,
antithrombotics (if ischaemic), DVT and pressure ulcer prophylaxis, physical
therapy and other supportive care. In addition, patients with suspected SAH
require sedation, analgesia, laxatives and possible early neurosurgical
referral. </span></p>
<p class=MsoNormal><span lang=EN-US>Post-discharge care should be planned in
consultation with the patient and/or caregivers. This may include palliative
care in patients with severe functional disability.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>CT scan and rehabilitation services may not
be readily accessible to most patients. Thrombolysis for stroke is currently
unavailable in The Gambia. </span></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Stroke typically presents as sudden,
rapidly peaking loss of neurological function. A history of sudden limb
weakness, slurring of speech or visual deficits suggests a stroke or, if
resolved within 24 hours, a transient ischaemic attack. Rarely, a stroke may
present with only paraesthesia, balance problems or language problems.</span></p>
<p class=MsoNormal><span lang=EN-US>Ask for head trauma within the past 3
months.</span></p>
<p class=MsoNormal><span lang=EN-US>If any of coma, neck stiffness, seizures,
diastolic blood pressure &gt; 110 mmHg, vomiting, or headache is also present,
the patient is more likely to have had a haemorrhagic type of stroke. A history
of sudden severe headache and neck stiffness is in keeping with subarachnoid
haemorrhage.</span></p>
<p class=MsoNormal><span lang=EN-US>A history of only loss of consciousness or
seizures suggests an alternative diagnosis. </span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoNormal><span lang=EN-US>Assess airway, breathing and circulation. Check
the observations (</span><span lang=EN-US>HR, BP, RR, O<sub>2</sub> sats,
Temperature).</span></p>
<p class=MsoNormal><span lang=EN-US>Assess consciousness, then orientation in
time, place and person. Observe for confusion and difficulty producing or
understanding speech.</span></p>
<p class=MsoNormal><span lang=EN-US>Check for neck stiffness which suggests
subarachnoid haemorrhage.</span></p>
<p class=MsoNormal><span lang=EN-US>Assess the pupils, eye movements and facial
symmetry. If patient is conscious, ask them to protrude their tongue.  </span></p>
<p class=MsoNormal><span lang=EN-US>Assess tone, power and reflexes across the
limbs.</span></p>
<p class=MsoNormal><span lang=EN-US>Observe the gait if the patient is able to
walk.</span></p>
<p class=MsoNormal><span lang=EN-US>Listen over the heart for rhythm, murmurs
and over the neck for carotid bruit.</span></p>
<h2><span lang=EN-US>Investigations</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood glucose as soon as possible (Both hypo-
and hyperglycaemia are stroke mimics. They also worsen stroke outcome)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>CT Scan of the brain without contrast to rule
out haemorrhage. This should be done same day if stable or next day (if
available and affordable).</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Full Blood Count</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ESR (helps exclude vasculitis in younger
patients)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Electrolytes, Urea and Creatinine</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Urinalysis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ECG (rule out atrial fibrillation)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>CXR</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Sepsis screen (if fever develops)</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Clotting profile (if previously on warfarin)</span></p>
<h2><span lang=EN-US style='font-size:11.0pt;font-weight:normal'>Aim to have
acted on the results for the above tests (excluding cultures) in less than four
hours.</span></h2>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Management </span></h2>
<h3><span lang=EN-US>Management in Gate Clinic</span></h3>
<p class=MsoNormal><span lang=EN-US>All patients with features of a possible
stroke (recent onset of facial weakness, limb weakness or speech problems)
should be referred immediately to the ward for urgent review by a doctor. </span></p>
<h3><span lang=EN-US>Management on the Ward</span></h3>
<p class=MsoNormal><u><span lang=EN-US>Assessment:</span></u></p>
<p class=MsoNormal><span lang=EN-US>Use the ROSIER (Recognition of Stroke in
the Emergency Room) score if uncertain of the diagnosis of stroke</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Feature</span></b></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Score</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Loss of consciousness or syncope</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>-1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Seizure activity</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>-1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Asymmetric facial weakness*</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>+1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Asymmetric arm weakness*</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>+1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Asymmetric leg weakness*</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>+1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Speech disturbance*</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>+1</span></p>
  </td>
 </tr>
 <tr>
  <td width=461 valign=top style='width:345.6pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Visual field defect*</span></p>
  </td>
  <td width=130 valign=top style='width:97.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>+1</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoListParagraph><span lang=EN-US>*of recent sudden onset or noticed
on waking from sleep</span></p>
<p class=MsoNormal><span lang=EN-US>If the total ROSIER score is less than 1, a
diagnosis of stroke is unlikely.</span></p>
<p class=MsoNormal><span lang=EN-US>Consider other diagnosis if the patient is young,
has gradual progression over days, is febrile or has papilloedema.</span></p>
<p class=MsoNormal><u><span lang=EN-US>Treatment:</span></u></p>
<p class=MsoNormal><u><span lang=EN-US>Starting at admission:</span></u></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hydrate initially with <b>IV normal saline</b>. </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nothing by mouth if dysarthric. Start on NG
tube. Repeat <b>swallow test</b> daily for conscious patients.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If there are signs of<b> raised ICP,</b> give IV
furosemide 40 mg bolus and IV mannitol 0.5 g/kg given over 20 minutes 4 - 6
hourly. </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Antithrombotics: If CT scan rules out
haemorrhage, commence <b>oral aspirin</b> at 300 mg daily for 4 weeks. For
patients without a CT scan but unlikely to have haemorrhagic stroke, start
aspirin on day 2 at 150 mg daily for 2 weeks. Reduce to 75 mg daily
subsequently.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>For suspected vasculitis (e.g raised ESR),
consider starting 1 mg per kg prednisolone.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>For stroke patients presenting in Keneba,
commence emergency care and refer immediately. </span></p>
<p class=MsoNormal style='line-height:150%'><u><span lang=EN-US>Starting after
24 hours:</span></u></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>DVT prophylaxis</span></b><span lang=EN-US>
with <b>heparin </b>after 2 days for immobile patients if hemorrhage is ruled
out or unlikely.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Early mobilization</span></b><span
lang=EN-US> of the patient is encouraged but minimize within first 24 hours.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Statins </span></b><span lang=EN-US>should be
commenced after 48 hours if patient is able to obtain the drug.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Treat <b>recurrent seizures</b> with oral
carbamazepine or valproate. </span></p>
<p class=MsoNormal style='line-height:150%'><u><span lang=EN-US>Ongoing
supportive care</span></u></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>10.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><b><span lang=EN-US>Supplemental Oxygen</span></b><span
lang=EN-US> should be given for patients with oxygen saturations below 94%.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>11.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-US>Keep <b>systolic BP</b> below 180 mmHg with oral
antihypertensives. Consider IV labetalol if systolic blood pressure is &gt;220
mmHg</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:17.85pt;text-indent:
-17.85pt;line-height:150%'><span lang=EN-US>12.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-US>Maintain <b>blood glucose</b> between 7.7 – 10
mmol/l. Hypoglycaemia should be identified and treated promptly. Hyperglycaemia
may require insulin therapy as discussed in the Diabetes Mellitus guideline. </span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>13.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-US>Maintain normal <b>body temperature</b>. Fever
&gt;37.5°C should be treated with paracetamol. Search for possible infections
and do sepsis screening. Avoid indwelling catheters if feasible, otherwise
monitor daily.</span></p>
<p class=MsoNormal><u><span lang=EN-US>SAH:</span></u></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:17.85pt;text-indent:-17.85pt;
line-height:150%'><span lang=EN-US>14.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-US>For suspected or confirmed subarachnoid
haemorrhage,  </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Keep systolic BP below 130 mmHg with a calcium
channel blocker but avoid hypotension</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Lactulose suspension to keep stools soft
(prevents straining and raised ICP)</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>c.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Oral diazepam for light sedation</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>d.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analgesics</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:54.0pt;text-indent:-18.0pt;
line-height:150%'><span lang=EN-US>e.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Consider early referral for neurosurgical
management especially for unconscious patients or sudden deterioration</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<h3><span lang=EN-US>Discharge planning and Post-Discharge Care</span></h3>
<p class=MsoNormal><span lang=EN-US>Discharge planning should involve the
patient, their caregivers at home and the clinical team. Stroke patients should
be discharged home when agreed-upon achievable goals of inpatient care have
been reached and the home environment made safe. Patients with severe residual
brain injury from stroke may require palliative care.</span></p>
<p class=MsoNormal><span lang=EN-US>Assess functional independence at discharge
</span></p>
<p class=MsoNormal><span lang=EN-US>Plan safe care at home e.g sturdy
arm-chairs resting against walls, wheelchairs, relocate patient to a
ground-floor bedroom, install hand-holds on walls.</span></p>
<p class=MsoNormal><span lang=EN-US>Explain stroke risk factors and
prescriptions to the patient and caregivers.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients with persistent swallowing
difficulties may be fed with thickened fluids if tolerated. For patients
requiring nasogastric feeding, discuss feasibility of a PEG tube insertion.</span></p>
<p class=MsoNormal><span lang=EN-US>Patient should be referred for physical and
psychological rehabilitation services. Regardless of clinical recovery,
patients with stroke should be advised not to drive for at least one month
post-discharge.</span></p>
<p class=MsoNormal><span lang=EN-US>Schedule first follow-up visit for 4 weeks
after discharge but advise caregivers to present early if they notice any deterioration
in the patient’s state.</span></p>
<h2><span lang=EN-US>Key Issues for Nursing care</span></h2>
<p class=MsoNormal><span lang=EN-US>Monitor vital signs every 4 hours. Call the
doctor if: </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Temperature &gt; 37.5, </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood glucose &lt; 6 mmol/l or &gt; 10 mmol/l</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Systolic blood pressure &lt; 140 or &gt; 180 mmHg</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>GCS drops by 1 point compared to last
observation</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Oxygen saturation &lt; 95%</span></p>
<p class=MsoNormal><span lang=EN-US>Nurse in 30 degrees head up position with
head in midline</span></p>
<p class=MsoNormal><span lang=EN-US>Two-hourly turning and surveillance for
pressure ulcers if unconscious/immobile</span></p>
<p class=MsoNormal><span lang=EN-US>Suction oral cavity and airway as needed if
unconscious</span></p>
<p class=MsoNormal><span lang=EN-US>Strict fluid charts</span></p>
<p class=MsoNormal><span lang=EN-US>Strict bed rest if SAH is suspected</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Prasad K, Kaul S,
Padma MV, Gorthi SP, Khurana D, Bakshi A. Stroke management. Ann Indian Acad
Neurol. 2011;14(Suppl 1):S82-96. </span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Berkowitz AL.
Managing acute stroke in low-resource settings. Bull World Health Organ.
2016;94(7):554-6. </span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Stroke and
transient ischaemic attack in over 16s: diagnosis and initial management. NICE
Guideline. March 2017</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Nor AM, Davis J,
Sen B, Shipsey D, Louw SJ, Dyker AG, Davis M, Ford GA. The Recognition of
Stroke in the Emergency Room (ROSIER) scale: development and validation of a
stroke recognition instrument.Lancet Neurol. 2005 Nov;4(11):727-34.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Medscape.
Subarachnoid haemorrhage. Available at: </span><span lang=EN-US><a
href="https://emedicine.medscape.com/article/1164341-overview"><span
style='font-size:10.0pt'>https://emedicine.medscape.com/article/1164341-overview</span></a></span><span
lang=EN-US style='font-size:10.0pt'> Accessed: 9<sup>th</sup> January 2019</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Fatai Akemokwe</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 09 January 2019</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest </span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 14 January 2019</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Previous guideline was updated and transferred onto the new
  template</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->
<div data-role="panel" data-position="right" data-display="overlay" data-position-fixed="true" data-theme="b" id="leftpanel1">
	<a href="#" data-rel="close" data-theme="b" class="ui-btn ui-corner-all ui-shadow ui-btn-a ui-icon-delete ui-btn-icon-notext ui-btn-right">Close</a>
  <h1>About this app</h1>
  <div>
    This app is designed to provide doctors and nurses with quick access to the clinical guidelines of the Clinical Services Department of the MRC Unit The Gambia at LSHTM. <br>Users will be notified of updates via departmental email. <br>For feedback or support, email fakemokwe@mrc.gm
  </div>
</div>
</div>
<div data-role="footer" data-tap-toggle="false" data-id="persistent-footer" data-position="fixed" data-theme="a">
  <a href="index.html" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-left ui-btn-icon-left ui-icon-home">Home</a>
  <a href="#" onclick="topFunction()" id="myBtn" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-right ui-btn-icon-right ui-icon-carat-u">Top</a>  
</div>
</body>
</html>
